Sustained anxiolytic and antidepressant effects of botulinum toxin A in blepharospasm patients beyond motor symptom control

doi:10.5498/wjp.v16.i1.112973

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

This Article

(41)

(30)

(0)

(629)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Psychiatry. Jan 19, 2026; 16(1): 112973
Published online Jan 19, 2026. doi: 10.5498/wjp.v16.i1.112973

Full Size Figure Download Figure

Figure 2 Flow diagram describing the study population, number included and excluded. BoNT-A: Botulinum toxin A; BEB: Benign essential blepharospasm.

Citation: He XY, Xu MY, Feng LY, Zhang JT, Jin LZ, Jin L, Ge JC, Zhang L, Zhang WB, Zhang L, Shen H, Yan J. Sustained anxiolytic and antidepressant effects of botulinum toxin A in blepharospasm patients beyond motor symptom control. World J Psychiatry 2026; 16(1): 112973
URL: https://www.wjgnet.com/2220-3206/full/v16/i1/112973.htm
DOI: https://dx.doi.org/10.5498/wjp.v16.i1.112973

He XY, Xu MY, Feng LY, Zhang JT, Jin LZ, Jin L, Ge JC, Zhang L, Zhang WB, Zhang L, Shen H, Yan J. Sustained anxiolytic and antidepressant effects of botulinum toxin A in blepharospasm patients beyond motor symptom control. World J Psychiatry 2026; 16(1): 112973 [PMID: 41607435 DOI: 10.5498/wjp.v16.i1.112973]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.